Recruiting
Restless legs syndrome
RecruitingStudy on the Effects of Ferric Derisomaltose and Dopaminergic Therapy for Patients with Restless Legs Syndrome
Registered drug
Study on the Effects of Ferric Derisomaltose and Dopaminergic Therapy for Patients with Restless Legs Syndrome
Registered drug
- Disease:Restless legs syndrome
- Substances:Ferric DerisomaltoseSodium Chloride
Countries:
Austria
Austria- Participants:18–64 years · 65+ years
- Substances:Ferric Derisomaltose
- Sponsor:Medizinische Universitaet Innsbruck



